About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 1475 record(s)
Req # A-2020-000101
Adverse Drug Reactions (ADRs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_02892422, E2B_02894493, E2B_02893564, E2B_02894473, E2B_02894312, E2B_02894529, E2B_02893595, E2B_02849955, E2B_02851962, E2B_02854267, E2B_02858217, E2B_02853264,…Organization: Health Canada
January 2022
Req # A-2020-000161
Adverse Drug Reactions (ADRs). Report numbers: E2B_02435687, E2B_02869601, E2B_02923477, E2B_02872789, E2B_02958369.Organization: Health Canada
January 2022
Req # A-2020-000534
Adverse Drug Reactions (ADRs) for INSULIN GLULISINE. Report numbers: 737158, E2B_02878646.Organization: Health Canada
January 2022
Req # A-2020-000601
Adverse Drug Reactions (ADRs) for Tylenol. Report numbers: 000195580, 000208708, 000212188, 000086837, 000087473, 000115760, 000140118, 000140713, 000141827, 000144564, 000144585, 000183286, 000147780, 000153004, 000156455, 000162302, 000162587,…Organization: Health Canada
January 2022
Req # A-2020-000685
Adverse Drug Reactions (ADRs). Report numbers: E2B_02925706, E2B_00208358, 000508544, 000912481, E2B_03105862, 000721970.Organization: Health Canada
January 2022
Req # A-2020-000742
Adverse Drug Reactions (ADRs) for Celexa. Report numbers: E2B_03038359, 909357, 910227, E2B_03091263, E2B_03089342, E2B_03082149, E2B_03072817, 910257, E2B_03074799, E2B_03161870, E2B_03168194, 915847, E2B_03126402, E2B_03123688, E2B_03152083,…Organization: Health Canada
January 2022
Req # A-2020-000939
Adverse Drug Reactions (ADRs). Report numbers: 000685109, 000690735, E2B_00803713, E2B_01106551, E2B_01073848, E2B_01073909, E2B_00859292, E2B_00865616, E2B_00317517.Organization: Health Canada
January 2022
Req # A-2020-001040
Adverse Drug Reactions (ADRs). Report numbers: 000722481, 000722482, 000722483, 000722485, 000722486, 000722487, 000722488, 000722489, 000722490, 000722496, 000722539, 000722549, 000722571, 000722800, 000722808, 000722814, 000722984, 000723097,…Organization: Health Canada
January 2022
Req # A-2020-001049
Adverse Drug Reactions (ADRs). Report numbers: E2B_02085546, E2B_02000502, E2B_02000495, E2B_02086683, E2B_02084819, E2B_02000494, E2B_01991682, E2B_01988364, E2B_01988596, E2B_01992826, E2B_01995229, E2B_02000514, E2B_02005142, E2B_02110294,…Organization: Health Canada
January 2022
Req # A-2020-001396
Adverse Drug Reactions (ADRs). Report numbers: E2B_02910133, E2B_02910235, E2B_02910449, E2B_02910545, E2B_02910613, E2B_02910987, E2B_02911262, E2B_02911455, E2B_02911465, E2B_02911560, E2B_02911622, E2B_02911635, E2B_02911867, E2B_02912289,…Organization: Health Canada
January 2022